Wu Xiaoyan, Li Xiaosi, Yu Junjie, Fan Chenliang, Shen Mengli, Li Xiangchen
Department of Laboratory Medicine, the Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang Province, China.
Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou, Zhejiang Province, China.
BMC Med Genomics. 2024 Oct 1;17(1):240. doi: 10.1186/s12920-024-02016-0.
This study aims to assess the in vitro drug susceptibility of various Carbapenemase-Producing Enterobacteriaceae (CPE) genotypes and elucidate the underlying mechanisms of amikacin resistance.
A total of 72 unique CPE strains were collected from the Second Hospital of Jiaxing between 2019 and 2022, including 51 strains of Klebsiella pneumoniae, 11 strains of Escherichia coli, 6 strains of Enterobacter cloacae, 2 strains of Klebsiella aerogenes, 1 strain of Citrobacter freundii, and 1strain of Citrobacter werkmanii. Among these strains, 24 carried bla gene, 20 carried bla gene, 23 carried bla gene, and 5 carried both bla and bla. We measured the in vitro activity of amikacin and other common antibiotics. Strains carrying bla-like gene were selected for whole genome sequencing (WGS) via next-generation sequencing to identify genes related to antimicrobial resistance (AMR) and virulence factor (VF).
Out of the 72 CPE strains tested, 41.7% exhibited resistance to amikacin. The drug resistance rates for K. pneumoniae, E. coli, and Enterobacter spp. were 51.0%, 27.3%, and 10.0%, respectively. The majority of the CPE strains (> 90%) displayed resistance to cephalosporins and carbapenems, while most of them were sensitive to polymyxin B and tigecycline (97.2% and 94.4%). The amikacin resistance rate was 100% for strains carrying bla, 20.8% for those with bla, 5.0% for those with bla, and 20.0% for those with both bla and bla. These differences were statistically significant (P < 0.05). Through sequencing, we detected aminoglycoside resistance genes rmtF and aac(6')-Ib, VF genes iucABCD and rmpA2 in OXA-48-producing multidrug resistance and highly virulent strains. These genes were located on a IncFIB- and IncHI1B-type plasmid, respectively. Both plasmids were highly homologous to the plasmid from OXA-232 strains in Zhejiang province and Shanghai province. Integration of these resistance genes into the IncFIB plasmid, facilitated by the IS6 and/or Tn3 transposons, resulted in OXA232-producing K. pneumoniae with amikacin resistance.
This study identified significant amikacin resistance in CPE strains, particularly in those carrying the bla gene. Resistance genes rmtF and aac(6')-Ib were identified on plasmids. These results highlight the need for careful monitoring of amikacin resistance.
本研究旨在评估各种产碳青霉烯酶肠杆菌科细菌(CPE)基因型的体外药敏情况,并阐明阿米卡星耐药的潜在机制。
2019年至2022年期间,从嘉兴市第二医院收集了72株独特的CPE菌株,包括51株肺炎克雷伯菌、11株大肠埃希菌、6株阴沟肠杆菌、2株产气克雷伯菌、1株弗氏柠檬酸杆菌和1株沃克曼柠檬酸杆菌。在这些菌株中,24株携带bla基因,20株携带bla基因,23株携带bla基因,5株同时携带bla和bla基因。我们测定了阿米卡星和其他常用抗生素的体外活性。通过下一代测序选择携带bla样基因的菌株进行全基因组测序(WGS),以鉴定与抗菌药物耐药性(AMR)和毒力因子(VF)相关的基因。
在测试的72株CPE菌株中,41.7%对阿米卡星耐药。肺炎克雷伯菌、大肠埃希菌和肠杆菌属的耐药率分别为51.0%、27.3%和10.0%。大多数CPE菌株(>90%)对头孢菌素和碳青霉烯类耐药,而大多数对多粘菌素B和替加环素敏感(分别为97.2%和94.4%)。携带bla基因的菌株阿米卡星耐药率为100%,携带bla基因的为20.8%,携带bla基因的为5.0%,同时携带bla和bla基因的为20.0%。这些差异具有统计学意义(P<0.05)。通过测序,我们在产OXA-48的多重耐药和高毒力菌株中检测到氨基糖苷类耐药基因rmtF和aac(6')-Ib、毒力因子基因iucABCD和rmpA2。这些基因分别位于IncFIB型和IncHI1B型质粒上。这两种质粒与浙江省和上海市OXA-232菌株来源的质粒高度同源。在IS6和/或Tn3转座子的作用下,这些耐药基因整合到IncFIB质粒中,导致产OXA232的肺炎克雷伯菌对阿米卡星耐药。
本研究发现CPE菌株中存在显著的阿米卡星耐药,尤其是携带bla基因的菌株。在质粒上鉴定出耐药基因rmtF和aac(6')-Ib。这些结果凸显了对阿米卡星耐药进行密切监测的必要性。